SAN JOSE, Calif.--(BUSINESS WIRE)--LifeMap Solutions, a digital-health subsidiary of BioTime, Inc. (NYSE MKT and TASE: BTX) known for its ResearchKit-enabled app Asthma Health, today announced that ...

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, a subsidiary of AgeX Therapeutics, Inc., announced today that it will be presenting its novel whole genome sequencing (WGS) interpretation solutions ...

ALAMEDA, Calif.--(BUSINESS WIRE)-- LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany ...

In the first third-party post to Apple's ResearchKit blog, mobile health provider LifeMap Solutions reports seeing high rates of consent and participation due in large part to iOS and iPhone app ...

Developed by a leading bioinformatics team at the Weizmann Institute of Science, GeneCards(R) is an online database that provides concise genomic, transcriptomic, genetic, proteomic, functional and ...

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. BTX, announced today the release of LifeMap Discovery^TM version 1.1 (discovery.lifemapsc.com). LifeMap Discovery^TM is a key component in LifeMap ...

BioTime, Inc., a biotechnology company focused on regenerative medicine and blood plasma volume expanders, and its subsidiary LifeMap Sciences have launched LifeMap ...

ALAMEDA, Calif.--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of MalaCards version 1.02 on January 7. The new release is available at ...

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap Discovery TM Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility According to Google Analytics, the ...

A new version of MyHeartCounts, one of the original ResearchKit apps, is now available. The app, which was developed by Stanford University and BioTime subsidiary LifeMap Solutions, measures activity ...